Long-Acting Injectables Curb Schizophrenia Readmission ...Middle East

Patients with schizophrenia discharged on an LAI antipsychotic had significantly lower 30-day psychiatric readmission rates than those sent home with an oral antipsychotic. Medscape Medical News

Hence then, the article about long acting injectables curb schizophrenia readmission was published today ( Wednesday 07/02/2024 - 10:24 AM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Long-Acting Injectables Curb Schizophrenia Readmission )

Also on site :

• Exclusive: Anthropic acknowledges testing new AI model representing ‘step change’ in capabilities, after accidental data leak reveals its existence
• Clarks' 'Stylish' Slingback Sandals Feel Like 'Walking on Clouds,' and They're Nearly 40% Off at Macy's
• 1965 Timeless Classic Ranked Among ‘Greatest Country Songs of All Time’ Became a Long-Running No. 1 Hit